| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Moxifloxacin Impurity |
莫西沙星雜質(zhì)80 |
2331091-31-5 |
詳細(xì)
|
| Baloxavir Impurity |
6,11-DIHYDRODIBENZO(B,E)THIEPIN-11-OL |
1745-46-6 |
詳細(xì)
|
| Baloxavir Impurity |
巴洛沙韋雜質(zhì)39 |
2814504-20-4 |
詳細(xì)
|
| Palonosetron Impurity |
帕洛諾司瓊雜質(zhì)2 |
1021456-82-5 |
詳細(xì)
|
| Lenacapavir Impurity |
2-((3BR,4AS)-5,5-二氟-3-(三氟甲基)-3B,4,4A,5-四氫-1H-環(huán)丙烷[3,4]環(huán)戊[1,2-C]吡唑-1 -基)乙酸 |
2189680-65-5 |
詳細(xì)
|
| Flurbiprofen Impurity |
4-乙酰基-2-氟聯(lián)苯 |
42771-79-9 |
詳細(xì)
|
| Ethanol, 2-[2-(4-nitroso-1-piperazinyl)ethoxy]- |
2-(2-(4-亞硝基哌嗪-1-基)乙氧基)乙醇 |
73486-81-4 |
詳細(xì)
|
| Dapagliflozin Impurity |
(5-溴-2-氯苯基)(4-乙氧苯基)甲酮 |
461432-22-4 |
詳細(xì)
|
| Azithromycin Impurity |
阿奇毒素相關(guān)物質(zhì)H |
612069-30-4 |
詳細(xì)
|
| Urapidil Impurity |
O-去甲烏拉地爾 |
91453-03-1 |
詳細(xì)
|
| Rivaroxaban Impurity |
利伐沙班開環(huán)n-甲基雜質(zhì) |
1807455-76-0 |
詳細(xì)
|
| Baloxavir Impurity |
Baloxavir Intermediate |
2305694-79-3 |
詳細(xì)
|
| Metoclopramide Impurity |
4-乙酰胺基-5-氯-N-(2-(二乙氨基)乙基)-2-甲氧基苯甲酰胺 |
5608-13-9 |
詳細(xì)
|
| Omadacycline 4-one Impurity |
奧瑪環(huán)素雜質(zhì)10 |
885112-31-2 |
詳細(xì)
|
| L-Ornithine |
鳥氨酸 |
70-26-8 |
詳細(xì)
|
| Rosuvastatin Impurity |
(3R,5S)-6-氯-3,5-二羥基己酸叔丁酯 |
154026-93-4 |
詳細(xì)
|
| Furosemide Impurity |
2,4-二(糠基氨基)-5-氨基磺?；郊姿?/td>
| 5046-19-5 |
詳細(xì)
|
| Mono-POC Isopropyl Tenofovir (Mixture of Diastereomers) |
O-(異丙氧羰基氧甲基)-O-異丙基-{(R)-[1-(6-氨基-9H-嘌呤-9-基)丙-2-基氧基]}甲基膦酰基 |
1246812-40-7 |
詳細(xì)
|
| Omadacycline Tosylate |
對(duì)甲苯磺酸奧瑪環(huán)素 |
1075240-43-5 |
詳細(xì)
|
| Alogliptin Impurity |
阿格列汀雜質(zhì) |
2089611-85-6 |
詳細(xì)
|
| Rosuvastatin Impurity |
4-(4-氟苯基)-6-異丙基-2-[(N-甲基-N-甲磺酰)氨基]嘧啶-5-甲醛 |
147118-37-4 |
詳細(xì)
|
| L-Glutamic acid 5-methyl ester |
L-谷氨酸-5-甲酯 |
1499-55-4 |
詳細(xì)
|
| Flutamide |
氟他胺 |
13311-84-7 |
詳細(xì)
|
| Minocycline Impurity |
Sancycline 7-Ethylmethylamino Impurity |
32598-29-1 |
詳細(xì)
|
| Metoclopramide ImpurityCl |
O-去甲鹽酸甲氧氯普安 |
38059-78-8 |
詳細(xì)
|
| N-Nitroso Fluoxetine |
氟西汀雜質(zhì)22 |
150494-06-7 |
詳細(xì)
|
| Penehyclidine Impurity |
N-乙酸乙酯-4-哌啶甲酸乙酯 |
1838-39-7 |
詳細(xì)
|
| Tofacitinib Impurity |
N-甲基-N-((3R,4R)-4-甲基哌啶-3-基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
477600-74-1 |
詳細(xì)
|
| Minocycline Impurity |
4-表米諾環(huán)素 |
43168-51-0 |
詳細(xì)
|
| Methylthiouracil |
甲基硫氧嘧啶 |
56-04-2 |
詳細(xì)
|
| Azithromycin Impurity |
阿奇霉素雜質(zhì)E |
612069-27-9 |
詳細(xì)
|
| (R,S)-Palonosetron HCl |
RS-鹽酸帕洛諾司瓊 |
135755-51-0 |
詳細(xì)
|
| (S,R)-Palonosetron HCl |
(S,R)-鹽酸帕洛諾司瓊 |
135729-76-9 |
詳細(xì)
|
| Urapidil Impurity |
2-脫甲氧基-2-氯烏拉地爾 |
34661-73-9 |
詳細(xì)
|
| Atropine sulfate Impurity |
托品酸 |
529-64-6 |
詳細(xì)
|
| Erlotinib Impurity |
埃羅替尼雜質(zhì)3 |
328528-74-1 |
詳細(xì)
|
| Vitamin B6 Photodegradable Impurity |
吡哆醛鹽酸鹽 |
65-22-5 |
詳細(xì)
|
| Urapidil Impurity |
1,2-雙-4-(2-甲氧基苯基)-1-哌嗪基-乙烷 |
108997-11-1 |
詳細(xì)
|
| Nicotinamide riboside |
煙酰胺核糖 |
1341-23-7 |
詳細(xì)
|
| Tofacitinib Impurity |
托法替尼雜質(zhì)16 |
2382711-65-9 |
詳細(xì)
|
| Agomelatine Impurity |
阿戈美拉汀雜質(zhì)34 |
2740380-64-5 |
詳細(xì)
|
| Omacycline 4-Beta isomer |
奧馬環(huán)素雜質(zhì)01 |
601455-29-2 |
詳細(xì)
|
| N-amidomacycline |
奧馬環(huán)素雜質(zhì)11 |
2272886-37-8 |
詳細(xì)
|
| Urapidil Impurity(Hydrochloride) |
1-(2-甲氧基苯基)哌嗪鹽酸鹽 |
5464-78-8 |
詳細(xì)
|
| Silagilan Impurity |
N-去甲鹽酸司來吉蘭 |
56862-28-3 |
詳細(xì)
|
| 4-chloro-6,7-dimethoxyquinazoline |
4-氯-6,7-二甲氧基喹唑啉 |
13790-39-1 |
詳細(xì)
|
| Methylprednisolone Impurity |
(1R,3aS,3bS,5S,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-iodoacetyl)-5,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one |
85847-53-6 |
詳細(xì)
|
| Flutamide Impurity |
4-硝基-3-三氟甲基苯胺 |
393-11-3 |
詳細(xì)
|
| Ceftriaxone Impurity |
AE-活性酯 |
80756-85-0 |
詳細(xì)
|
| Empagliflozin ImpurityOE |
恩格列凈雜質(zhì)POE |
2452301-14-1 |
詳細(xì)
|
| Azithromycin Impurity |
紅霉素肟A |
111321-02-9 |
詳細(xì)
|
| Naloxone EP Impurity F |
納洛酮EP雜質(zhì)F |
2139253-69-1 |
詳細(xì)
|
| Minocycline Impurity |
地美環(huán)素 |
127-33-3 |
詳細(xì)
|
| Esomeprazole Impurity |
埃索美拉唑雜質(zhì)I |
158812-85-2 |
詳細(xì)
|
| Glycyrrhetinic Acid Impurity |
甘草皂苷G2 |
118441-84-2 |
詳細(xì)
|
| Probucol USP Related Compound C |
4-[(3,5-二叔丁基-2-羥基苯硫基)異亞丙基乙氧基]-2,6-二叔丁基苯酚 |
1391054-68-4 |
詳細(xì)
|
| Empagliflozin Impurity |
甲基 1-C-[4-氯-3-[[4-[[(3S)-四氫-3-呋喃基]氧基]苯基]甲基]苯基]-ALPHA-D-吡喃葡萄糖苷 |
1279691-36-9 |
詳細(xì)
|
| β-Nicotinamide Mononucleotide |
β-煙酰胺單核苷酸 |
1094-61-7 |
詳細(xì)
|
| Vortioxetine Impurity |
沃替西汀雜質(zhì)01 |
2135576-73-5 |
詳細(xì)
|
| Azelastine Impurity(Hydrochloride) |
氮卓斯汀雜質(zhì)11 DIHCL |
169123-29-9 |
詳細(xì)
|
| Minocycline (Hydrochloride) |
鹽酸米諾環(huán)素 |
13614-98-7 |
詳細(xì)
|
| Isavuconazole Impurity |
艾沙康唑雜質(zhì) 14 |
1797905-83-9 |
詳細(xì)
|
| Penehyclidine N-oxide |
戊乙奎醚雜質(zhì)1 |
2564756-90-5 |
詳細(xì)
|
| Methotrexate Impurity |
氨甲蝶呤雜質(zhì)55 |
2801801-56-7 |
詳細(xì)
|
| Glycyrrhetinic Acid Impurity |
18α-甘草次酸 |
1449-05-4 |
詳細(xì)
|
| Benzbromarone Impurity |
6-甲氧基-2-甲基苯并呋喃 |
29040-48-0 |
詳細(xì)
|
| Tedizolid Phosphate |
磷酸特地唑胺 |
856867-55-5 |
詳細(xì)
|
| Flurbiprofen Impurity |
氟比洛芬雜質(zhì)5 |
124635-84-3 |
詳細(xì)
|
| Butenafine Impurity |
布替萘芬雜質(zhì)13 |
101846-86-0 |
詳細(xì)
|
| Fluticasone Propionate Impurity |
6Α,9Α-二氟-11Β-羥基-16Α-甲基-3-氧代-17Α-(丙酰氧基)雄甾-1,4-二烯-17 Β-羧酸 |
65429-42-7 |
詳細(xì)
|
| Octreotide Impurity |
L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]- (9CI) |
133304-81-1 |
詳細(xì)
|
| Minocycline Impurity |
米諾環(huán)素雜質(zhì)25 |
4656-99-9 |
詳細(xì)
|
| 2-deamideomacycline |
奧馬環(huán)素雜質(zhì)8 |
2272886-34-5 |
詳細(xì)
|
| Palonosetron N-Oxide |
帕洛諾司瓊N氧化物 |
813425-83-1 |
詳細(xì)
|
| Ezetimibe Impurity |
依澤替米貝去氟代類似物 |
302781-98-2 |
詳細(xì)
|
| Empagliflozin Impurity |
(3S)-3-[4-[(5-溴-2-氯苯基)甲基]苯氧基]四氫呋喃 |
915095-89-5 |
詳細(xì)
|
| Brexpiprazole Impurity |
依匹哌唑氮氧化物 |
1191900-58-9 |
詳細(xì)
|
| Tris(hydroxymethyl)aminomethane |
三（羥甲基）氨基甲烷 |
77-86-1 |
詳細(xì)
|
| Mosapride Impurity |
4-氨基-5-氯-2-乙氧基苯甲酸 |
108282-38-8 |
詳細(xì)
|
| Glycyrrhetinic Acid Impurity |
甘草次酸 |
471-53-4 |
詳細(xì)
|
| Flurbiprofen Impurity |
氟比洛芬雜質(zhì)6 |
124635-86-5 |
詳細(xì)
|
| Faroenem Impurity |
(2R,Z)-2-((1S,2R)-1-羧基-2-羥丙基)-5-(4-羥基丁烯)-2,5-二氫噻唑-4-羧酸-1-氧化物 |
774505-06-5 |
詳細(xì)
|
| Octreotide Impurity |
醋酸奧曲肽雜質(zhì)E |
1546983-27-0 |
詳細(xì)
|
| Vitamin B6 Impurity |
(4-羥基-5-甲基吡啶-2,3-二基)二甲醇 |
221624-94-8 |
詳細(xì)
|
| N-Acetyl Desloratadine |
乙酰地氯雷他定 |
117796-52-8 |
詳細(xì)
|
| Chlorphenamine Impurity |
2,2'-二吡啶胺 |
1202-34-2 |
詳細(xì)
|
| Rivaroxaban Impurity |
N,N'-二[{(5S)-2-氧代-3-[4-(3-氧代-4-嗎啉基)苯基]-1,3-惡唑啉-5-基}甲基]苯基-1,2-二酰胺 |
1365267-36-2 |
詳細(xì)
|
| Erlotinib |
埃羅替尼 |
183321-74-6 |
詳細(xì)
|
| Esomeprazole Impurity |
2-巰基-5-甲氧基苯并咪唑 |
37052-78-1 |
詳細(xì)
|
| Celecoxib Impurity |
塞來昔布雜質(zhì)17 |
2247197-65-3 |
詳細(xì)
|
| Dapagliflozin Impurity |
5-溴-2-氯苯甲酸 |
21739-92-4 |
詳細(xì)
|
| Bumetanide Impurity |
布美他尼雜質(zhì)6 |
1236290-34-8 |
詳細(xì)
|
| Etoricoxib Impurity |
依托考昔雜質(zhì)39 |
1017593-53-1 |
詳細(xì)
|
| Tofacitinib Impurity |
托法替尼相關(guān)化合物35 |
2459302-85-1 |
詳細(xì)
|
| Octreotide Impurity |
奧曲肽EP雜質(zhì)B |
1211530-36-7 |
詳細(xì)
|
| Mosapride Impurity(Hydrochloride) |
莫沙必利脫氟芐基雜質(zhì) |
152344-08-6 |
詳細(xì)
|
| Miglitol Impurity 10 |
1221793-46-9 |
1221793-46-9 |
詳細(xì)
|
| Faroenem Impurity |
2-Thiazoleacetic acid,4-carboxy-2,5-dihydro-5-(4-hydroxybutylidene)-a-[(1R)-1-hydroxyethyl]-, disodium salt, (aS,2R,5Z)- (9CI) |
130609-10-8 |
詳細(xì)
|
| Baloxavir Impurity |
巴洛沙韋酯雜質(zhì)9 |
1985606-48-1 |
詳細(xì)
|
| Upadacitinib Impurity |
烏帕替尼雜質(zhì)3 |
2304514-60-9 |
詳細(xì)
|